Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Azelastine

Summary

Persistence. It cannot be excluded that azelastine is persistent, due to the lack of data.

Bioaccumulation. It cannot be excluded that azelastine bioaccumulates, due to the lack of data.

Toxicity. It cannot be excluded that azelastine is toxic, due to the lack of data.

Risk. Risk of environmental impact of azelastine cannot be excluded, due to the lack of environmental toxicity data.

 

Environmental information is missing on fass.se for azelastine (2024-07-03).

Detailed information

An article by Richmond et al.

Azelastine has been found in in caddisfly larvae.

Pharmaceuticals residues in the aquatic environment in Region Stockholm, Sweden

Azelastine has been monitored in wastewater, surface water and drinking water within Region Stockholm, but was below the quantification limit in 2021.

References

  1. Richmond EK, Rosi EJ, et al. A diverse suite of pharmaceuticals contaminates stream and riparian food webs. Nat Commun. 2018 Nov 6;9(1):4491. doi: 10.1038/s41467-018-06822-w.
  2. Provtagningar av läkemedelsrester i vatten, sediment och fisk för Region Stockholm.
  3. IVL Swedish Environmental Research Institute Ltd. Fick J, Lindberg RH, Kaj L, Brorström-Lundén E. Results from the Swedish National Screening Programme 2010. Subreport 3. Pharmaceuticals.
  4. IVL Swedish Environmental Research Institute Ltd Fick J, Lindberg RH, Fång J, Magnér J, Kaj L, Brorström-Lundén E. Screening 2014. Analysis of pharmaceuticals and hormones in samples from WWTPs and receiving waters. Rapport C 135.

Author: Health and Medical Care Administration, Region Stockholm